Aberxin-Localized Production and Innovation in the Fragrance Market

As one of the first international fragrance companies to enter the Chinese market, Aberxin has always implemented the "Made in China for China" strategy.

The capping of its new factory in Zengcheng, Guangzhou in 2024 (expected to be delivered this year) will further enhance its localized production capacity and support the rapid growth of the therapeutic fragrance market in the Asia-Pacific region.

Aberxin will continue to deliver solutions that combine aesthetics and therapeutic value through fragrance technology innovation and cultural integration.Mass skincare needs are complex and ever-changing.

With the explosion of skincare demands in various scenarios after the Spring Festival—such as seasonal changes leading to sensitivity, back-to-school and work routines, overnight recovery, and post-medical aesthetic procedures—brands in the skincare and beauty industry are also presented with new opportunities for growth.

In response to the diverse and individualized skincare issues often described as "a thousand people, a thousand faces," niche products that contain technological ingredients and focus on functions like barrier repair and stabilizing springtime sensitivity have become new favorites among consumers.